Found: 14
Select item for more details and to access through your institution.
A MicroRNA Next-Generation-Sequencing Discovery Assay (miND) for Genome-Scale Analysis and Absolute Quantitation of Circulating MicroRNA Biomarkers.
- Published in:
- International Journal of Molecular Sciences, 2022, v. 23, n. 3, p. 1226, doi. 10.3390/ijms23031226
- By:
- Publication type:
- Article
Neural mechanisms of eye contact when listening to another person talking.
- Published in:
- Social Cognitive & Affective Neuroscience, 2017, v. 12, n. 2, p. 319, doi. 10.1093/scan/nsw127
- By:
- Publication type:
- Article
Preserved T cell responses to SARS-CoV-2 in anti-CD20 treated multiple sclerosis.
- Published in:
- Multiple Sclerosis Journal, 2022, v. 28, n. 7, p. 1041, doi. 10.1177/13524585221094478
- By:
- Publication type:
- Article
Are there Epstein–Barr virus seronegative patients with multiple sclerosis?
- Published in:
- 2013
- By:
- Publication type:
- Letter
The brain reacting to COVID-19: analysis of the cerebrospinal fluid proteome, RNA and inflammation.
- Published in:
- Journal of Neuroinflammation, 2023, v. 20, n. 1, p. 1, doi. 10.1186/s12974-023-02711-2
- By:
- Publication type:
- Article
Meningitis gone viral: description of the echovirus wave 2013 in Germany.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Targeting Transcutaneous Spinal Cord Stimulation Using a Supervised Machine Learning Approach Based on Mechanomyography.
- Published in:
- Sensors (14248220), 2024, v. 24, n. 2, p. 634, doi. 10.3390/s24020634
- By:
- Publication type:
- Article
Multiple Sclerosis Is Rare in Epstein-Barr Virus-Seronegative Children with Central Nervous System Inflammatory Demyelination.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Anti‐CD20 therapy for multiple sclerosis‐associated uveitis: A case series.
- Published in:
- European Journal of Neurology, 2022, v. 29, n. 10, p. 3028, doi. 10.1111/ene.15453
- By:
- Publication type:
- Article
Ferroptosis inhibitor improves outcome after early and delayed treatment in mild spinal cord injury.
- Published in:
- Acta Neuropathologica, 2024, v. 147, n. 1, p. 1, doi. 10.1007/s00401-024-02758-2
- By:
- Publication type:
- Article
Humoral immune responses remain quantitatively impaired but improve qualitatively in anti-CD20-treated patients with multiple sclerosis after three or four COVID-19 vaccinations.
- Published in:
- Multiple Sclerosis Journal, 2023, v. 29, n. 7, p. 884, doi. 10.1177/13524585231161253
- By:
- Publication type:
- Article
The fraction of varicella zoster virus-specific antibodies among all intrathecally-produced antibodies discriminates between patients with varicella zoster virus reactivation and multiple sclerosis.
- Published in:
- Fluids & Barriers of the CNS, 2014, v. 11, n. 1, p. 2, doi. 10.1186/2045-8118-11-3
- By:
- Publication type:
- Article
Epstein-Barr virus antibodies in serum and DNA load in saliva are not associated with radiological or clinical disease activity in patients with early multiple sclerosis.
- Published in:
- PLoS ONE, 2017, v. 12, n. 4, p. 1, doi. 10.1371/journal.pone.0175279
- By:
- Publication type:
- Article
Comprehensive analysis of the cerebrospinal fluid and serum metabolome in neurological diseases.
- Published in:
- Journal of Neuroinflammation, 2024, v. 21, n. 1, p. 1, doi. 10.1186/s12974-024-03218-0
- By:
- Publication type:
- Article